Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT
Journal of Medicinal Chemistry · 25.06.2026 · 69 (12) · 14191-14212
DOI: 10.1021/acs.jmedchem.5c03558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 10.06.2026. Verfasst von Ganga Reddy Velma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, MAP Kinase Kinase Kinases, Nicotinamide Phosphoribosyltransferase, Protein Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: BLRD VA, U.S. Department of Defense, National Institute on Aging.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States.
- Department of Surgery, Division of Surgical Oncology, The University of Illinois Chicago, Chicago, Illinois 60612, United States.
- University of Illinois Hospital & Health Sciences System Cancer Center, The University of Illinois Chicago, Chicago, Illinois 60612, United States.
- UICentre for Drug Discovery, The University of Illinois Chicago, Chicago, Illinois 60612, United States.
- Jesse Brown VA Medical Center, Chicago, Illinois 60612, United States.
ORCID-Profile: Ganga Reddy Velma, Piush Srivastava, Rui Xiong, Gregory R J Thatcher
Förderung
- BLRD VA
- U.S. Department of Defense
- National Institute on Aging
Zitieren
APA
Velma, G. R., Kumar, S., Srivastava, P., Misra, S., Sathish Nair, R., Musku, S. R., Ackerman-Berrier, M., Singh, S. K., Vyas, H., Alves, E. T. M., Rana, B., Xiong, R., Bloem, L., Rana, A., & Thatcher, G. R. J. (2026). Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT. Journal of Medicinal Chemistry, 69(12), 14191-14212. https://doi.org/10.1021/acs.jmedchem.5c03558
Vancouver
Velma GR, Kumar S, Srivastava P, Misra S, Sathish Nair R, Musku SR, et al. Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT. Journal of Medicinal Chemistry. 2026;69(12):14191-14212. doi:10.1021/acs.jmedchem.5c03558
BibTeX
@article{Velma2026,
author = {Velma, Ganga Reddy and Kumar, Sandeep and Srivastava, Piush and Misra, Sweta and Sathish Nair, Rakesh and Musku, Soumya Reddy and Ackerman-Berrier, Martha and Singh, Sunil Kumar and Vyas, Harsh and Alves, Erick T M and Rana, Basabi and Xiong, Rui and Bloem, Laura and Rana, Ajay and Thatcher, Gregory R J},
title = {Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPT},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {12},
pages = {14191--14212},
doi = {10.1021/acs.jmedchem.5c03558}
}
EUVIMED